Dr Benedict M. Reynolds, an American surgeon, reignited interest in the condition in his 1959 report with colleague Dr Everett L. Dargan, and formulated the pentad that carries his name. It remained a condition generally treated by surgeons, with exploration of the bile duct and excision of gallstones, until the ascendancy of ERCP in 1968. ERCP is generally performed by internal medicine or gastroenterology specialists. In 1992 it was shown that ERCP was generally safer than surgical intervention in ascending cholangitis. See also
Primary sclerosing cholangitis (an autoimmune disease leading to narrowing of the bile ducts)
Gallstone-related pancreatitis

References


== External links ==
Research
Mogamulizumab is being explored as a treatment for HTLV-1–Associated Myelopathy. An early Phase 1-2a study showed decreased in proviral loads, as well as inflammatory markers in the CSF. 79% of the patients showed reduction in spasticity and 32% showed decrease in motor disability. References
External links
"Mogamulizumab". Drug Information Portal. U.S. National Library of Medicine. "Mogamulizumab-kpkc". National Cancer Institute. 30 August 2018. "Mogamulizumab-kpkc". NCI Drug Dictionary. National Cancer Institute.